Point of Care Testing
暂无分享,去创建一个
[1] Point-of-care testing in the intensive care unit. The intensive care physician's perspective. , 1995, American journal of clinical pathology.
[2] L. Sokoll,et al. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. , 1999, Surgery.
[3] E. Spitznagel,et al. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial , 1999, The Lancet.
[4] B. Sibbald,et al. Impact of introducing near patient testing for standard investigations in general practice. , 1993, BMJ.
[5] S J Steindel,et al. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. , 1999, Journal of healthcare management / American College of Healthcare Executives.
[6] R. Jones,et al. An evaluation of near‐patient testing for Helicobacter pylori in general practice , 1997, Alimentary pharmacology & therapeutics.
[7] L. Brandi,et al. Five to 10 years follow-up after total parathyroidectomy and autotransplantation of parathyroid tissue: evaluation of parathyroid function by use of ischaemic blockade manoeuvre. , 1996, Scandinavian journal of clinical and laboratory investigation.
[8] R. Grieve,et al. Near patient testing in diabetes clinics: appraising the costs and outcomes. , 1999, Health technology assessment.
[9] R K Ditchburn,et al. A study of microscopical and chemical tests for the rapid diagnosis of urinary tract infections in general practice. , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.
[10] B Littenberg,et al. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. , 1991, American journal of clinical pathology.
[11] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[12] J Lindemans,et al. Portable blood gas and electrolyte analyzer evaluated in a multiinstitutional study. , 1999, Clinical chemistry.
[13] Dry Reagent Chemistries , 1983 .
[14] L. Goodnough,et al. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. , 1997, Clinical chemistry.
[15] U. Müller,et al. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group. , 1999, Diabetes & metabolism.
[16] J A Brunelle,et al. Simultaneous measurement of total hemoglobin and its derivatives in blood using CO-oximeters: analytical principles; their application in selecting analytical wavelengths and reference methods; a comparison of the results of the choices made. , 1996, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[17] N. D. de Wit,et al. Tests for Helicobacter pylori infection: a critical appraisal from primary care. , 2000, Family practice.
[18] D. Nathan,et al. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. , 1999, Diabetes care.
[19] C A Parvin,et al. Impact of point-of-care testing on patients' length of stay in a large emergency department. , 1996, Clinical chemistry.
[20] D. Burnett. Accreditation and point-of-care testing , 2000, Annals of clinical biochemistry.
[21] W. Palatnick,et al. Effect of point of care testing on length of stay in an adult emergency department. , 1999, The Journal of emergency medicine.
[22] P. St-Louis. Status of point-of-care testing: promise, realities, and possibilities. , 2000, Clinical biochemistry.
[23] R. Winkens,et al. The validity of urine examination for urinary tract infections in daily practice. , 1995, Family practice.
[24] G. Dahlquist,et al. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus , 1999, Diabetologia.
[25] M. Gulliford,et al. Monitoring blood glucose control in diabetes mellitus: a systematic review. , 2000, Health technology assessment.
[26] Yaochun Shen,et al. Advances in photoacoustic noninvasive glucose testing. , 1999, Clinical chemistry.
[27] J. Lott,et al. Comparison of instrument‐read dipsticks for albumin and creatinine in urine with visual results and quantitative methods , 1998, Journal of clinical laboratory analysis.
[28] D. Fitzmaurice,et al. Anticoagulation management in primary care: a trial-based economic evaluation. , 2000 .
[29] S. Walters,et al. Costs and benefits of community postnatal support workers: a randomised controlled trial. , 2000, Health technology assessment.
[30] O. C. Olson. Diagnosis and Management of Diabetes Mellitus , 1988 .
[31] Paul Fenn,et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) , 2000, BMJ : British Medical Journal.
[32] M. Clancy,et al. Point of care testing: randomised controlled trial of clinical outcome , 1998, BMJ.
[33] M. Berkus,et al. Intensified versus conventional management of gestational diabetes. , 1994, American journal of obstetrics and gynecology.
[34] J. Widness,et al. Clinical performance of an in-line point-of-care monitor in neonates. , 2000, Pediatrics.
[35] J. W. A. S. Sander,et al. IMMEDIATE ANTICONVULSIVE DRUG MONITORING IN MANAGEMENT OF EPILEPSY , 1987, The Lancet.
[36] E. DeLong,et al. Impact of Glucose Self-Monitoring on Non-lnsulin-Treated Patients With Type II Diabetes Mellitus: Randomized Controlled Trial Comparing Blood and Urine Testing , 1990, Diabetes Care.
[37] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[38] O. Khalil,et al. Spectroscopic and clinical aspects of noninvasive glucose measurements. , 1999, Clinical chemistry.
[39] S. Griffin,et al. Diabetes care in general practice: meta-analysis of randomised control trials. , 1998, BMJ.
[40] C. Price. Evidence-based laboratory medicine: supporting decision-making. , 2000, Clinical chemistry.
[41] A. Simor,et al. Rapid detection of infectious mononucleosis-associated heterophile antibodies by a novel immunochromatographic assay and a latex agglutination test , 1993, Journal of clinical microbiology.
[42] J A Lott,et al. Comparison of urine dipsticks with quantitative methods for microalbuminuria. , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[43] H. Bodansky,et al. A Novel Device for the Rapid In‐clinic Measurement of Haemoglobin A1c , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[44] John Pickup,et al. In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring , 1999, BMJ.
[45] M. Clancy,et al. The Portable Laboratory: An Evaluation of the Accuracy and Reproducibility of i-STAT© , 1999, Annals of clinical biochemistry.
[46] C. Price,et al. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. , 1999, Clinical chemistry.
[47] M. Scott. Faster is better--it's rarely that simple! , 2000, Clinical chemistry.
[48] M. Galloway,et al. An audit of waiting times in a haematology clinic before and after the introduction of point-of-care testing. , 1999, Clinical and laboratory haematology.
[49] W. Maughan,et al. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. , 2000, Clinical chemistry.
[50] B Walter,et al. Solid-phase reagent strips for detection of therapeutic drugs in serum by substrate-labeled fluorescent immunoassay. , 1983, Analytical chemistry.
[51] K. Nicolaides,et al. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester , 2000 .
[52] R. Bellazzi,et al. Building telemedicine systems for supporting decisions in diabetes care: a report from a running experience. , 2000, Diabetes technology & therapeutics.
[53] J. Piette,et al. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? , 2000, The American journal of medicine.
[54] K. Porter,et al. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. , 1999, The Journal of trauma.
[55] E. Antman,et al. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. , 1995, JAMA.
[56] B. Luce,et al. The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model , 1998, American journal of medical quality : the official journal of the American College of Medical Quality.
[57] M. Farrow,et al. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. , 1995, Journal of clinical pathology.
[58] G. Irvin,et al. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. , 1999, Annals of surgery.
[59] J. Bonnar,et al. Personal hormone monitoring for contraception. , 1999, The British journal of family planning.
[60] E. Furth,et al. AccuStat whole blood fingerstick test for Helicobacter pylori infection: a reliable screening method. , 1998, Journal of clinical gastroenterology.
[61] H. Chin,et al. Successful implementation of a comprehensive computer-based patient record system in Kaiser Permanente Northwest: strategy and experience. , 1998, Effective clinical practice : ECP.
[62] A. Turner,et al. Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor. , 1986, Biosensors.
[63] G. Valkirs,et al. ImmunoConcentration--a new format for solid-phase immunoassays. , 1985, Clinical chemistry.
[64] M. Moia,et al. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). , 2000, Haematologica.
[65] E. Ohman,et al. Relation between inhibition of platelet aggregation and clinical outcomes. , 1998, American heart journal.
[66] J A Lott,et al. Evaluation of an automated urine chemistry reagent‐strip analyzer , 1995, Journal of clinical laboratory analysis.
[67] Prithipal Singh,et al. A noninstrumented quantitative test system and its application for determining cholesterol concentration in whole blood. , 1990, Clinical chemistry.
[68] J. Donovan,et al. Diagnosis, management and screening of early localised prostate cancer. , 1997, Health technology assessment.
[69] H. Katus,et al. Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[70] F D Hobbs,et al. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. , 2000, Archives of internal medicine.
[71] L. Jovanovic,et al. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.
[72] P. Sawicki,et al. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. , 1999, JAMA.
[73] J. Marx,et al. Value of point-of-care blood testing in emergent trauma management. , 2000, The Journal of trauma.
[74] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[75] P Wilding,et al. Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. , 1993, Clinical chemistry.
[76] A. Shenhav,et al. Simultaneous detection of seven drugs of abuse by the Triage panel for drugs of abuse. , 1992, Clinical chemistry.
[77] R. Califf,et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. , 1999, The American journal of cardiology.
[78] Doug Hirst,et al. Keeping the spotlight on quality from a distance , 2000 .
[79] D. Fitzmaurice,et al. A review of near patient testing in primary care. , 1997, Health technology assessment.
[80] E. Spitznagel,et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.
[81] T. Northfield,et al. Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: laboratory or near‐patient testing? , 1998, European journal of gastroenterology & hepatology.
[82] B. Peterson,et al. Nurse Case Management To Improve Glycemic Control in Diabetic Patients in a Health Maintenance Organization , 1998, Annals of Internal Medicine.
[83] R H Christenson,et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. , 1999, Clinical chemistry.